[Latest] Global Transgenic Animals Market Size/Share Worth USD 7.89 Billion by 2035 at a 10.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Charles River Laboratories International Inc CRL
$150.85
▼ -5.20%
($-8.27)
Index member:
S&P 500
Open
$157.54
Prev Close
$159.12
Day Range
$149.98 – $160.26
52W Range
$132.58 – $228.88
Market Cap
$8.11B
Beta
1.42
EPS (TTM)
$-3.76
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2000-06-23 |
| Shares Out. | 49,340,000 |
| Website | criver.com/ ↗ |
| Phone | 17812226000 |
Charles River Laboratories International Inc is a publicly traded company under the ticker symbol CRL on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-05-01)
📰 Latest News for CRL
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Charles River And MEDIPOST Enter Into Strategic, Non-Exclusive MOU To Collaborate On GMP-Compliant Testing To Advance Cell Therapy Development And Commercialization
CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
Charles River Laboratories International, Inc. Accelerates Digital Pathology with Ai-Powered End-To-End Workflow
Is It Time To Rethink Charles River Laboratories (CRL) After Its Recent Price Rebound?